Camber Capital Management LP - Q2 2013 holdings

$972 Million is the total value of Camber Capital Management LP's 43 reported holdings in Q2 2013. The portfolio turnover from Q1 2013 to Q2 2013 was - .

 Value Shares↓ Weighting
No holdings reported for quarter Q2 2013
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2013-08-21
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TEVA PHARMACEUTICALS INDS LTD34Q3 20239.7%
BROOKDALE SR LIVING INC32Q3 20235.0%
PERRIGO CO PLC29Q3 20237.1%
TENET HEALTHCARE CORP28Q3 20238.5%
NEKTAR THERAPEUTICS28Q1 20229.8%
UNIVERSAL HLTH SVCS INC25Q3 20239.9%
MYRIAD GENETICS INC24Q3 20235.0%
SAREPTA THERAPEUTICS INC23Q3 20236.0%
MYLAN NV21Q3 202010.1%
AMAG PHARMACEUTICALS INC21Q3 20204.0%

View Camber Capital Management LP's complete holdings history.

Latest significant ownerships (13-D/G)

View Camber Capital Management LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
SC 13G2023-10-30

View Camber Capital Management LP's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export Camber Capital Management LP's holdings